Global Pharmaceutical News

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

A Degree in Health Science Could Be Just What the Doctor Ordered

The FDA has placed a clinical hold on Hemogenyx Pharmaceuticals’ investigational HEMO-CAR-T, which is being trialed for the treatment of acu

Amid declining demand for COVID-19 vaccines, embattled biotech Novavax is revising its advanced purchase contract with Canada’s department o

angioedema patients treated with Intellia’s NTLA-2002—an in vivo CRISPR-Cas9 therapy— had an average 95% reduction in the sudden, debilitati

Pioneer Group has announced a partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on t

Johnson & Johnson has capitalized on the shaky financial ground at French biotech Nanobiotix by licensing its lead product, NBTXR3, intended

Chinese biotech BeiGene has acquired an exclusive license of an investigational antibody-drug conjugate for $1.3 billion from Shanghai-based

A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t

GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients TME Pharma – a company concentrating on the develo

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint

Therapy has been developed to reduce the frequency, duration and severity of migraine attacks

European Innovation Council Accelerator finances treatment development drive for condition

SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation

Biotech firms target weight-loss drugs without Wegovy's side-effects, QUNATUNG Pharma

Incyte Biosciences has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for

Orkambi is an oral treatment for very young children that combines both lumacaftor and ivacaftor

Researchers leading the University of Oxford’s Com-COV3 study have delivered results from a study researching the immune response and side-e